Author

Alessandro Scapozza

University of GenevaORCID 0009-0000-2232-6974Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Approach:statistical model· 1

Frequent Co-Authors

Aurélie GouilleriD· 1 shared Camila D. Arcuschin· 1 shared Camille Süess· 1 shared Carolina Di BenedettoiD· 1 shared Cecilia Schwarzer· 1 shared David PejoskiiD· 1 shared Denise P. MuñoziD· 1 shared Dietmar J. KappesiD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Aurélie GouillerORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyCellular and Molecular Life SciencesPeer-reviewedNov 13, 2025

Super-enhancer profiling reveals ThPOK/ZBTB7B, a CD4+ cell lineage commitment factor, as a master regulator that restricts breast cancer cells to a luminal non-migratory phenotype

Camila D. Arcuschin, Kamin Kahrizi, Rosalyn W. Sayaman…·Denise P. Muñoz

The paper identifies ThPOK/ZBTB7B as a master regulator that restricts breast cancer cells to a luminal non-migratory phenotype by suppressing metastatic pathways.

2 citations

humanbulk RNA-seq

𝕏 PostBluesky

Pharmacology & ToxicologyJournal of Medicinal ChemistryPeer-reviewedJan 24, 2025

Discovery of the first-efficacious A2AR negative allosteric modulators for high adenosine cancer immunotherapies

Margot Boujut, Margaux Héritier, Aurélie Gouiller…·Léonardo Scapozza

The paper identifies potent A2AR negative allosteric modulators through high-throughput screening and SAR analysis, showing their efficacy in high-adenosine conditions for safer cancer immunotherapies.

8 citations

humanexperimental assay

𝕏 PostBluesky